Alan Perlman is a Nephrology physician affiliated with Weill Cornell Medicine. OpenAlex indexes 19 publications with 1,373 citations (h-index 10); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
505 E 70th St
2nd Floor
New York, NY 100214872
Telephone
212-249-4061Provider last certified this registry record 17 Jul 2024.
Clinical trials
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Sponsor: The Rogosin Institute
- Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease
Sponsor: The Rogosin Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202515 payments$19,509openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year20251 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.2%Calcium channel blocker12.1%Amlodipine Besylate83%Nifedipine Er17%Part D<11 patientsAngiotensin receptor blocker (ARB)12%Losartan Potassium51%Valsartan34%Olmesartan Medoxomil15%Part D<11 patients+ 8 more classes in this area
Metabolism & gastrointestinal
24.2%SGLT2 inhibitor15.9%Farxiga77%Jardiance23%Part D≥45 patientsVitamin D3 Analog5.8%Calcitriol100%Part D≥25 patients+ 3 more classes in this area
Other
7.3%Phosphate Binder4.1%Sevelamer Carbonate100%Part D≥19 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia3.3%Lokelma77%Lanthanum Carbonate23%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Urinary Plasminogen as a Marker of Disease Progression in Human Glomerular Disease
American Journal of Kidney Diseases
2024 - Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Annals of Internal Medicine
2023 - Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
American Journal of Kidney Diseases
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jedd Wolchok, MD
Weill Cornell Medicine
Richard Devereux, MD
Weill Cornell Medicine
Ronald Crystal, MD
Weill Cornell Medicine
Robert Harrington, MD
Weill Cornell Medicine
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”